Reversing Mixed Chimerism in Sickle Cell Disease: A Case for Extended Immunosuppression Following Allogeneic Hematopoietic Stem Cell Transplant

Key Points

• Reversing mixed chimerism improves patient outcomes after hematopoietic stem cell transplant.
• In a single patient case, lengthened immunosuppression led to significant health improvements.
• The analysis focused on the interaction between mixed chimerism and sickle cell disease management.
• Findings suggest extended immunosuppression may enhance transplant success in specific conditions.